{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Menopausal+Women&page=2", "query": { "condition": "Menopausal Women", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Menopausal+Women&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-07-24T08:29:42.298Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07042516", "title": "Safety and Efficacy of Asimadoline (TP0052) in Patients With Vasomotor Symptoms (VMS).", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Vasomotor Symptoms" ], "interventions": [ { "name": "Asimadoline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Tioga Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "62 Years", "sex": "FEMALE", "summary": "40 Years to 62 Years · Female only" }, "enrollment_count": 120, "start_date": "2025-08-13", "completion_date": "2027-02-20", "has_results": false, "last_update_posted_date": "2025-09-09", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07042516" }, { "nct_id": "NCT00484861", "title": "Effect of Diet on Vascular Disease in Pre-Menopausal Women", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Cardiovascular Diseases", "Vascular Disease", "Inflammation", "Insulin", "Triglycerides" ], "interventions": [], "intervention_types": [], "sponsor": "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)", "sponsor_class": "NIH", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "18 Years to 65 Years · Female only" }, "enrollment_count": 47, "start_date": "2007-06-07", "completion_date": "2017-02-14", "has_results": false, "last_update_posted_date": "2019-12-17", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00484861" }, { "nct_id": "NCT00802360", "title": "MENOPUR® Versus FOLLISTIM®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Infertility" ], "interventions": [ { "name": "Menotropin", "type": "DRUG" }, { "name": "Progestrone vaginal insert", "type": "DRUG" }, { "name": "follitropin beta", "type": "DRUG" }, { "name": "Progesterone in oil", "type": "DRUG" }, { "name": "Ganirelix", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ferring Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "42 Years", "sex": "FEMALE", "summary": "18 Years to 42 Years · Female only" }, "enrollment_count": 173, "start_date": "2008-12", "completion_date": "2010-01", "has_results": true, "last_update_posted_date": "2011-11-02", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 7, "location_summary": "Pasadena, California • San Diego, California • Littleton, Colorado + 4 more", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Littleton", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "Naperville", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT00802360" }, { "nct_id": "NCT05549505", "title": "A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer" ], "interventions": [ { "name": "ARV-471", "type": "DRUG" }, { "name": "Anastrozole", "type": "DRUG" }, { "name": "Surgical resection of breast tumor", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "Arvinas Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 152, "start_date": "2023-02-15", "completion_date": "2024-07-25", "has_results": true, "last_update_posted_date": "2025-08-29", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 13, "location_summary": "Springdale, Arkansas • Los Angeles, California • Torrance, California + 10 more", "locations": [ { "city": "Springdale", "state": "Arkansas" }, { "city": "Los Angeles", "state": "California" }, { "city": "Torrance", "state": "California" }, { "city": "Van Nuys", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT05549505" }, { "nct_id": "NCT03704454", "title": "The Use of Pycnogenol® to Alleviate Menopausal Symptoms Induced or Increased by Breast and Gynecological Cancer Treatments", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Climacteric; Menorrhagia, Menopausal", "Menopause" ], "interventions": [ { "name": "50 mg PYC and then placebo", "type": "DIETARY_SUPPLEMENT" }, { "name": "100 mg PYC and then placebo", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo and then 50 mg PYC", "type": "DIETARY_SUPPLEMENT" }, { "name": "Placebo and then 100 mg PYC", "type": "DIETARY_SUPPLEMENT" } ], "intervention_types": [ "DIETARY_SUPPLEMENT" ], "sponsor": "Legacy Health System", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "FEMALE", "summary": "18 Years to 99 Years · Female only" }, "enrollment_count": 40, "start_date": "2018-10-01", "completion_date": "2020-09-15", "has_results": false, "last_update_posted_date": "2018-10-12", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 3, "location_summary": "Gresham, Oregon • Portland, Oregon • Tualatin, Oregon", "locations": [ { "city": "Gresham", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Tualatin", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03704454" }, { "nct_id": "NCT06049797", "title": "A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Hot Flashes" ], "interventions": [ { "name": "Fezolinetant", "type": "DRUG" }, { "name": "Paroxetine", "type": "DRUG" }, { "name": "Citalopram", "type": "DRUG" }, { "name": "Escitalopram", "type": "DRUG" }, { "name": "Desvenlafaxine", "type": "DRUG" }, { "name": "Venlafaxine", "type": "DRUG" }, { "name": "Gabapentin", "type": "DRUG" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Pregabalin", "type": "DRUG" }, { "name": "Oxybutynin", "type": "DRUG" }, { "name": "Any other SSRI/SNRI not already specified", "type": "DRUG" }, { "name": "Any other non-hormonal pharmacologic therapy prescribed for the treatment of VMS not included in a category above", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Astellas Pharma Global Development, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "FEMALE", "summary": "40 Years to 75 Years · Female only" }, "enrollment_count": 999, "start_date": "2023-11-15", "completion_date": "2026-05-07", "has_results": false, "last_update_posted_date": "2026-06-05", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 48, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Lomita, California + 39 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lomita", "state": "California" }, { "city": "Pomona", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06049797" }, { "nct_id": "NCT01808040", "title": "A Phase 1b Study of TAK-700 in Postmenopausal Women With Hormone-receptor Positive Metastatic Breast Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Post Menopausal, Hormone Receptor Positive Breast Cancer" ], "interventions": [ { "name": "TAK700", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 8, "start_date": "2012-11", "completion_date": "2016-12-09", "has_results": false, "last_update_posted_date": "2019-11-18", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01808040" }, { "nct_id": "NCT07408440", "title": "Transdermal Testosterone Gel for Female Sexual Interest and Arousal Disorder in Peri- and Post Menopause", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Menopause", "Sexual Dysfunction", "Libido Disorder", "Testosterone Deficiency" ], "interventions": [ { "name": "Transdermal testosterone gel", "type": "OTHER" }, { "name": "Transdermal placebo gel", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "The University of Texas Health Science Center, Houston", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "65 Years", "sex": "FEMALE", "summary": "40 Years to 65 Years · Female only" }, "enrollment_count": 150, "start_date": "2026-04-01", "completion_date": "2028-03-30", "has_results": false, "last_update_posted_date": "2026-02-17", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07408440" }, { "nct_id": "NCT07526948", "title": "Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Menopausal Complaints", "Vaginal Atrophy", "Genitourinary Symptoms", "HIV (Human Immunodeficiency Virus)", "Menopause Related Conditions", "Vaginitis", "Perimenopause" ], "interventions": [ { "name": "Vaginal estradiol tablets", "type": "DRUG" }, { "name": "Vaginal moisturizer", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Albert Einstein College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "40 Years", "maximum_age": "70 Years", "sex": "FEMALE", "summary": "40 Years to 70 Years · Female only" }, "enrollment_count": 62, "start_date": "2026-06-01", "completion_date": "2031-06-30", "has_results": false, "last_update_posted_date": "2026-04-14", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "The Bronx, New York", "locations": [ { "city": "The Bronx", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT07526948" }, { "nct_id": "NCT00634608", "title": "Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Allergic Rhinitis", "Asthma", "Back Pain", "Benign Prostatic Hypertrophy", "Bursitis", "Depression", "Anxiety", "Diabetes Mellitus", "Esophageal Reflux", "HIV Infections", "Hyperlipidemia", "Hypertension", "Insomnia", "Irritable Bowel Syndrome", "Obesity", "Osteoporosis (Senile)", "Shoulder Pain", "Sinusitis", "Symptomatic Menopause", "Urinary Incontinence", "Urinary Tract Infection", "Vaginitis" ], "interventions": [ { "name": "Health Information Prescription", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Missouri-Columbia", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 224, "start_date": "2008-02", "completion_date": "2009-09", "has_results": false, "last_update_posted_date": "2016-09-30", "last_synced_at": "2026-07-24T08:29:42.298Z", "location_count": 1, "location_summary": "Columbia, Missouri", "locations": [ { "city": "Columbia", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00634608" } ] }